Open access
Oct 2026
Assessment of patient-reported outcomes for sleep status and daytime functioning with vornorexant administration: results from a randomized phase 3 pivotal study
The beneficial effects of vornorexant on subjective sleep status and daytime functioning as assessed by using standardized subjective assessment tools in patients with insomnia are supported, and its broad clinical relevance is suggested as a therapeutic option to treat insomnia.
Yusuke Miyazaki, Daiji Kambe, Sayaka Hasegawa et al.
· Sleep and Biological Rhythms · 0 citations